ResearchSafe

Bufotenin cardiovascular effects, anyone actually monitored BP and HR during it?

Posted by tracker_jade in Safety & Side Effects - 2 points, 6 comments.

So I keep seeing bufotenin come up in discussions and the thing that jumps out at me is the cardiovascular profile. It apparently has strong peripheral effects on top of the central stuff, which sounds different from the other tryptamines where the BP and HR spikes are more about the intensity of the experience itself. Anecdotally I have seen people brush off the cardiovascular side of 5-MeO and DMT as just transient, and yeah the half-life is minutes so it passes quick. But bufotenin seems like it could hit harder in a way that matters if someone already has elevated BP or any kind of arrhythmia history.

Has anyone here actually taken blood pressure readings before, during, and after a bufotenin experience? I am curious whether the flushing and nausea track with a measurable BP spike or if it is more of a subjective thing. Also wondering if anyone has looked at whether the route matters here, like yopo snuff versus other methods, since the traditional use is nasal and that hits fast.

I am not planning to try this myself right now, just trying to understand the real risk profile versus the other short-acting tryptamines. Any actual numbers people have seen would be helpful.

Comments

  • curious_scientist: I have not tried bufotenin myself so I cannot give you real numbers, but the peripheral serotonin receptor angle is what makes me wary here. Bufotenin has much higher affinity for 5-HT2A in peripheral tissue compared to something like DMT, imo that is not a trivial difference. Peripheral 5-HT2A activation causes vasoconstriction and that flushing people describe is probably real vascular response, not just subjective discomfort. The route question is smart. Nasal absorption skips first-pass met
  • greg_codes: The peripheral 5-HT2A angle is the part that worries me too. Vasoconstriction from peripheral receptor activation is not something you can just breathe through for 10 minutes and shake off, especially if someone's baseline BP is already sitting high. Ngl the nasal route skipping first-pass makes the peak sharper but also less predictable? Like at least with oral you get some metabolic buffering. Would be keen to see if anyone here actually tracked BP during a session, even just a cuff reading a
  • fasted_scientist: The peripheral 5-HT2A point is fair enough but I'd want to see actual receptor binding data comparing bufotenin vs DMT before calling it a meaningful difference. A lot of this stuff gets repeated from one forum post to the next without anyone going back to the source. Do you have a specific study in mind or is this from secondary sources? Not having a go, genuinely curious because the vasoconstriction claim gets thrown around a lot.
  • tracker_jade: I haven’t got a primary study handy, mostly seeing the vasoconstriction claim in trip reports and secondary summaries. If you’ve got a binding affinity paper, I’d love to see it. Meanwhile I’m still after any before/during/after BP logs from anyone who’s tried it.
  • tracker_jade: Yeah the first-pass thing is exactly what I was getting at with the route question. Nasal skipping metabolism means you get a sharper peak but less of that metabolic buffering you mentioned, and that seems like the worst combo for cardiovascular effects specifically. Have you seen anyone compare oral versus nasal for the flushing intensity alone? Like even without BP numbers, if the flushing is noticeably worse one way that might tell us something about how much peripheral receptor activation is
  • tracker_jade: The vasoconstriction angle is exactly what I was getting at, so thanks for spelling that out. The flushing being actual vascular response and not just discomfort makes me more cautious about it. Your point about nasal skipping first-pass is interesting, but would oral actually be safer BP-wise then since first-pass knocks down the peripheral hit, or does it just stretch the spike out longer?

Community discussion - research and educational context only. Not medical advice.